EQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...

Inventurus Knowledge Solutions (IKS), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced talks to acquire Nasdaq-lis...

ChrysCapital, led by MD Kshitij Sheth, aims to acquire Indian companies in the formulation business with potential valuations of $200 milli...

Indian private equity firm ChrysCapital has raised $700 million in new funds, allowing the firm to maintain its stake in India's National S...

ChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...

Private equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bi...

ResultsCX provides automation-driven customer support, acquisition, enrolment, retention, membership assistance, technical support and tran...

Chrys Capital IX would be the largest by an India-specific fund manager

The transaction involved a combination of secondary sale by an existing PE investor, BanyanTree Growth Capital, along with a primary raise ...

ChrysCapital is in exclusive discussions with Credo Brands Marketing, the owner of Mufti, and is completing due diligence ahead of signing ...

ChrysCapital will continue to hold a 3% stake in Intas, making it the longest and probably the most successful private equity investment in...

ChrysCapital has made 80 investments in India and exited 60 of these since its inception. The fund claims to have realised over $4 billion ...

ChrysCapital's $30-million cheque in the L&T Infotech IPO marks its return to public market investing after big, profitable exits from Info...

ChrysCapital has sold its 11% stake in Mankind Pharma to Capital International for little over $200 million, or Rs 1,300 crore.

FMCG firm CavinKare today said Mauritius-based private equity firm ChrysCapital has invested Rs 250 crore in it for an undisclosed stake

Although the stake could not be be confirmed, the pre-IPO deal will increase ChrysCapital's holding in the company to over 15% from 11.3% c...

ChrysCapital, which manages total assets of $2 bn, will also see the exit of Brahmal Vasudevan, one of its managing directors, by year-end.